Filing Flows › DataMeds AI (MEDS) › Q2 2025
DataMeds AI (MEDS) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 19, 2025
DataMeds AI (MEDS) reported revenue of $7.8M for the second quarter 2025 (Q2 2025), up 175-fold from a year earlier and -28% from the quarter before. Operating margin was -70.6%, net loss $6.7M (85.6% of revenue).
DataMeds AI, Q2 2025: revenue $7.8M (175× year over year), operating margin -70.6%, net loss $6.7M, operating cash flow −$2.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | -28% | 175× |
| Operating profit | −$5.5M | — | — |
| Net earnings | −$6.7M | — | — |
| Operating cash flow | −$2.1M | — | — |
What changed
Revenue was $7.8M in Q2 2025, up 17392% year over year and down 28% from the previous quarter. Product was the largest line at 97% of revenue. Pharmacy Retail Sales added $33K year over year (up 75%), 0% of the total change.
Gross margin was 6.5%. Operating costs exceeded revenue by $5.5M, an operating margin of -70.6%. The fastest-growing cost line was General & admin (+752%). The quarter ended with a net loss of $6.7M, narrower than the previous quarter's $32.4M loss.
Operating cash flow was −$2.1M. Non-cash charges added back $803K of depreciation and amortization and $935K of share-based compensation. Working capital and other items added $2.9M.
Questions
What was DataMeds AI's revenue in the second quarter 2025?
DataMeds AI (MEDS) reported revenue of $7.8M for the second quarter 2025 (Q2 2025), up 175-fold from a year earlier and -28% from the quarter before.
Was DataMeds AI profitable in the second quarter 2025?
Operating loss was $5.5M (-70.6% of revenue) and net loss $6.7M.
Source: DataMeds AI 10-Q on SEC EDGAR.